ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications.
Article in Oncology Nursing Forum (June 2022)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy.
Article in Journal of Oncology Pharmacy Practice (May 2022)
Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer
Article in Journal of Drug Assessment (December 2020)